Pulmonary thromboembolism is a significant complication of COVID-19 who were admitted to ICU

Afbeelding

Objectives:
What is the weighted average incidence of pulmonary thromboembolism (PTE) in COVID-19 patients who were admitted to the intensive care unit (ICU)?

Study design:
This review article included 14 observational studies with a total of 1,182 COVID-19 patients Almost all patients in this meta-analysis (review article) received at least prophylactic anticoagulation.

Males was a significant source of heterogeneity [p = 0.03, 95% CI = 0.00 to -0.09].

Results and conclusions:   
The investigators found the weighted average incidence of pulmonary thromboembolism was 11.1% [95% CI = 7.7% to 15.7%, I2 = 78%, p 0.01].

The investigators concluded the weighted average incidence of pulmonary thromboembolism remains high even after prophylactic anticoagulation. Pulmonary thromboembolism is a significant complication of COVID-19 especially in critically ill patients in the intensive care unit (ICU). 

Original title:
The incidence of pulmonary thromboembolism in COVID-19 patients admitted to the intensive care unit: a meta-analysis and meta-regression of observational studies by Jie J, Liang ZC and Choong AMTL.

Link:
https://pubmed.ncbi.nlm.nih.gov/33618760/

Additional information of El Mondo:
Find more information/studies on corona virus right here.

Pulmonary embolism (PE) is when a blood clot (thrombus) becomes lodged in an artery in the lung and blocks blood flow to the lung.